A New Generation of Drugs Could Lower Heart Attack Risk for Millions
P.M. Edition for May 27. Pharmaceutical companies have been testing a new type of drug to lower levels of lipoprotein(a); high levels have been linked to heart disease and can’t be lowered with diet and exercise. WSJ reporter Xavier Martinez walks us through how the new drugs work and what is still needed before they…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from WSJ What’s News
See all episodes →Similar episodes from other shows
More like WSJ What’s News →
Iran Retaliates After U.S. Strike. How Could This End?
Oil Prices Jump as U.S. and Iran Resume Strikes, and Big Tobacco Makes a Big New Bet
US, Iran agree ceasefire deal as Trump heads to G7 summit
Trump's Iran Negotiations, Entertainment Mergers, NBA finals
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.